Sells dental implant systems and orthodontic products to dental professionals.
10-K for FY2025, filed Feb 12, 2026Our Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative…View ↗
We are a world leader in the field of innovative Dental Implant Solutions, offering a full portfolio of solutions that enable dentists to…View ↗
For over 60 years, our Orthodontic Solutions businesses have provided orthodontic professionals with high quality, innovative products…View ↗
Envista sells equipment, consumables and spare parts, with product sales tied to shipment; customers often pay in advance, while extended warranty and service income is spread over the arrangement term.
10-K for FY2025, filed Feb 12, 2026
10-K for FY2025, filed Feb 12, 2026
FY2025 revenue by reportable segment ↗$2.7B
10-K for FY2025, filed Feb 12, 2026
$2.7B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Specialty Products & Technologies
Mix
10-K for FY2025, filed Feb 12, 2026 |
64%
FY2022: 62%
|
Specialty Products & Technologies, FY2025
$1.8B Sources
|
Mix |
|
Equipment & Consumables
Mix
10-K for FY2025, filed Feb 12, 2026 |
36%
FY2022: 38%
|
Equipment & Consumables, FY2025
$966.7M Sources
|
Mix |
Dental specialists, general dentists, dental laboratories and dental service organizations buy Envista's products; Specialty Products & Technologies is typically sold directly, while Equipment & Consumables mainly goes through channel partners.
10-K for FY2025, filed Feb 12, 2026Our Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative…View ↗
Our Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices…View ↗
Typical customers and end-users of our products include dental specialists such as orthodontists, periodontists, implantologists and…View ↗
10-K for FY2025, filed Feb 12, 2026
Sales to the Company’s largest customer were 12% of total sales for the year ended December 31, 2025 and 10% for the years ended December…View ↗
Yes. It kept 2 cents of every revenue dollar as net income in FY2025 and turned 8 cents into free cash flow.
10-Q for Q3 FY2026, filed Nov 4, 2026
$508.3MView ↗
10-Q for Q3 FY2026, filed Nov 4, 2026
Open tableView ↗
8-K, filed Aug 19, 2026
On August 17, 2026, upon the recommendation of the Nominating and Governance Committee of the Board, the Board appointed Paul Keel, the…View ↗
8-K, filed Aug 5, 2026
“We built on our fast start in Q1 with continued good performance in Q2,” said Paul Keel, CEO. “We delivered growth across both our…View ↗
Growing. Revenue grew 8% in 4 years, from $2.5B in FY2021 to $2.7B in FY2025, about 2% a year.
Intraoral scanner line
Envista has expanded its intraoral scanner portfolio with DEXIS Imprevo; previously, it acquired a scanner business and software portfolio.
10-K for FY2022, filed Feb 16, 2023 10-K for FY2025, filed Feb 12, 2026On April 20, 2022, we completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner…View ↗
Our Diagnostic Solutions business is focused on dental imaging, X-ray, and intraoral scanner solutions used in dental offices, clinics and…View ↗
Loading...